Your browser doesn't support javascript.
Isopp 2023
Journal of Oncology Pharmacy Practice Conference: 21st Symposium of the International Society of Oncology Pharmacy Practitioners, ISOPP ; 29(2 Supplement), 2023.
Artigo em Inglês | EMBASE | ID: covidwho-20245493
ABSTRACT
The proceedings contain 109 papers. The topics discussed include dose intensity of palbociclib and initial body weight dosage implications on progression free survival in 220 patients with ER+/HER2-negative metastatic breast cancer;characteristics of Nirmatrelvir/Ritonavir (Paxlovid) recipients and clinical interventions by oncology pharmacists at a tertiary outpatient cancer center;safe handling of non-carcinogenic drugs in the Ghent University Hospital development, implementation and communication of hospital-specific guidelines;case series use of olaparib in uncommon locations in patients with impaired homologous recombination;real-world data evaluation of medicines used in special situations in oncohematology a retrospective study from a comprehensive cancer institution;Dostarlimab in the treatment of recurrent endometrial cancer real life experience;medication-related osteonecrosis of the jaws and CDK4/6 inhibitors in breast cancer;and efficacy and safety outcomes of generic imatinib in adults with chronic myeloid leukemia (CML) following the switch from branded imatinib.
Palavras-chave
Buscar no Google
Coleções: Bases de dados de organismos internacionais Base de dados: EMBASE Tipo de estudo: Estudo experimental / Estudo observacional / Estudo prognóstico Idioma: Inglês Revista: Journal of Oncology Pharmacy Practice Conference: 21st Symposium of the International Society of Oncology Pharmacy Practitioners, ISOPP Ano de publicação: 2023 Tipo de documento: Artigo

Similares

MEDLINE

...
LILACS

LIS

Buscar no Google
Coleções: Bases de dados de organismos internacionais Base de dados: EMBASE Tipo de estudo: Estudo experimental / Estudo observacional / Estudo prognóstico Idioma: Inglês Revista: Journal of Oncology Pharmacy Practice Conference: 21st Symposium of the International Society of Oncology Pharmacy Practitioners, ISOPP Ano de publicação: 2023 Tipo de documento: Artigo